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Abstract
Posttraumatic stress disorder (PTSD) occurs at double the rate in individuals
undergoing  lung  transplantation,  compared  to  the  normal  population.  The
psychological  sequela  of  PTSD  makes  recovery  more  challenging  and  may
result  in  poor  medical  and  psychological  outcomes.  A series  of  three  cases
illustrate  this  presentation.  In  all  cases,  PTSD history  and  symptomatology
was  undisclosed  prior  to  lung  transplantation,  despite  robust  psychological
evaluation.  All  patients  experienced  traumatic  delirium  during  the  acute
recovery phase from transplantation. Re-emergence and exacerbation of PTSD
symptoms  related  to  remote  trauma  lasting  up  to  2  years  after  transplant.
Noncompliance with post-transplant recovery occurred in the sample of cases
presented. Major surgeries, such as lung transplant may exacerbate premorbid
PTSD possibly via psychological sequela such as delirium, regardless of type
or  remoteness  of  trauma  experiences.  Existing  psychological  evaluation
practices may not be adequate to capture PTSD as many patients may fail to













Posttraumatic stress disorder (PTSD), a debilitating psychological condition
triggered by experiencing or witnessing a traumatic event such as the threat of
death, serious injury, or sexual violence, that is associated with intrusive
thoughts, avoidance of trauma reminders, worsening cognition and mood, and
marked alterations in arousal and reactivity (American Psychiatric Association,
2013), occurs at double the rate in lung transplant recipients (12–15%
prevalence) (Gries et al., 2013) compared to the general population (Kessler et
al., 2005). The increased prevalence of PTSD in lung transplant recipients occurs
despite data to suggest a history of childhood trauma is high, but comparable
between lung transplant candidates (24.2%) (Kennedy, Zubair, Clark, & Jowsey-
Gregoire, 2016) and the general population (20–50%) (Springer, Sherida, Kuo, &
Carnes, 2003). Past studies have indicated patients undergoing lung
transplantation may be at higher risk for developing PTSD due to the (1)
psychological distress of having life-threatening lung disease and transplant
surgery, (2) intensive care unit (ICU) stay with increased risk of medical trauma
and/or delirium, and (3) lifelong fear of rejection, and ultimately, death
(Davydow, Lease, & Reyes, 2015; Gries et al., 2016). The exposure to post-
transplant medical trauma in combination with delirium may trigger or
exacerbate symptoms of PTSD. In fact, post-surgical delirium, characterized by
acute disturbance in attention and cognition, has been documented in as many as
37% of lung transplant recipients (Anderson et al., 2018). Lung transplant
recipients may have greater risk for delirium because of medical sequelae
uniquely resulting from transplantation, such as lower mean intra-operative
cerebral perfusion pressure and primary graft dysfunction (Smith et al., 2016).
However, the impact of a pre-existing history of trauma exposure and PTSD on
post-transplant recovery is less clear.
2 of 11
We present three illustrative cases of transplant patients who, in the immediate
and acute post-transplant phase of treatment, experienced robust symptoms of
PTSD predating their lung transplantation and lung disease history. Notably, no
trauma history was disclosed during an intensive pre-transplant psychological
work-up. These cases suggest that (1) exposure to anesthesia and high-dose
steroids, commonly used in lung transplantation, particularly can result in
delirium and trigger new or exacerbate latent PTSD, (2) history of trauma and
resulting PTSD may be difficult to discover by transplant teams, even with
robust psychological evaluation, (3) the remoteness of incident trauma and
resulting PTSD, despite stable presentation, may not decrease the risk of adverse
outcomes following lung transplantation.
Case 1
“Ms. A” was a 69-year-old woman who received a single-lung transplant for
interstitial lung disease. She had no known psychiatric history prior to transplant
and was identified as a good transplant candidate psychologically. She was
referred to the psychology team 2 months following her transplant, while she was
in the ICU, due to refusal to participate in physical therapy or use her bi-level
positive airway pressure device at night, resulting in hypoxia. Ms. A initially
denied psychological difficulties underlying her behavior and attributed her poor
compliance and irritability to uncontrolled pain. She was hospitalized for over
5 months following lung transplantation, mainly because of lack of progress
towards physical therapy goals due to noncompliance.
Following discharge, Ms. A disclosed to the transplant psychologist her
experience of severe delirium for 3 days following her lung transplantation, in
which she thought she was in the Vietnam War constantly running from enemy
soldiers, which was extremely traumatic for her. Upon further query, she
acknowledged she had a history of childhood abuse, however, she declined to
give further details, as she found memories of her trauma too disturbing to
discuss. She endorsed a significant increase in flashbacks to her original trauma
in the months following her transplant and acknowledged that these flashbacks
impacted her ability to adequately participate in physical therapy while
hospitalized. Ms. A attributed her noncompliant behavior while admitted post-
transplant to this combination of post-transplant delirium and worsening PTSD
from childhood abuse. She refused treatment for her PTSD symptoms, even after
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appropriate diagnosis, as she did not feel ready to discuss her trauma, and made
minimal gains in her progress with physical therapy over the 2 months following
her disclosure of PTSD symptoms.
Case 2
“Ms. B” was a 57-year-old woman who received a bilateral lung transplant for
pulmonary fibrosis. No significant psychological concerns were noted by the
transplant team. Two years after her transplant, she was referred to transplant
psychology due to a depressed mood and sudden weight gain. Ms. B reported her
initial post-transplant course included severe delirium in which she thought she
had witnessed her nurse and doctor having an affair and plotting to kill her by
giving her an overdose of medication. Looking back on her experience with
delirium, she stated: “I know it didn’t happen, but I can remember it like it did.
Even to this day, I can see everything clearly.”
Ms. B also revealed she is a survivor of multiple rapes, which occurred during
adolescence. Consequently, she experienced severe untreated PTSD symptoms in
her early adulthood. Ms. B stated she thought she had recovered from her PTSD
prior to transplant and did not think it was relevant to inform the team of her
trauma history. She reported that her post-transplant delirium reminded her of her
past traumas, as she felt a similar lack of control. Mrs. B’s undisclosed and
untreated PTSD likely increased her susceptibility to traumatic and persecutory
delirium content, and the delirium context likely exacerbated her PTSD
symptoms. She reported lingering feelings of guilt related to her traumas and
delirium. Ms. B reported continuing to be bothered by her delirium years after
transplant.
Ms. B received a brief course of modified cognitive processing therapy for her
remaining PTSD symptoms at the time of referral. She also opted to become
involved with activism events for women’s rights issues and to discuss her
history of sexual trauma and its impact on her wellbeing with friends and family.
Her symptoms resolved in 2 months and she made significant gains in
compliance with dietary and exercise recommendations.
Case 3
“Mr. C” was a 69-year-old male who underwent bilateral lung transplant for
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pulmonary fibrosis. No major concerns were noted by psychology prior to
transplant. He served in the Navy during the Vietnam War, but initially denied
being exposed to combat trauma during his service. During his initial post-
transplant hospitalization, he requested psychological services for delirium and
nightmares that he attributed to PTSD. Mr. C revealed that during the war, he
was stationed on a boat that overlooked a battlefield on which he saw soldiers
dying “all day every day for 6 months.” Mr. C stated that in the 3 days following
transplant, he experienced intense delirium, consisting of a continuous flashback
to his service in the Vietnam War. He reported seeing uniformed soldiers in his
hospital room for several weeks following transplant and experiencing frequent
nightmares related to his combat trauma.
AQ2
Mr. C also reported a secondary trauma in which he learned his son had been
arrested for sexually abusing Mr. C’s granddaughter. In addition to his re-
experiencing symptoms of combat trauma during hospitalization, Mr. C reported
an increase in guilt related to his son’s molestation of his granddaughter, which
he attributed to the limited time they spent together as his son was maturing due
to Mr. C’s deployments and estrangement from his son’s mother.
He denied having experienced trauma during his pre-transplant psychological
evaluation because he was concerned his family, who was not aware of his prior
exposure to trauma, would be upset. Mr. C’s active PTSD symptoms likely also
contributed to his significant medically unexplained pain management problems
during his hospitalization, which worsened with increased PTSD symptoms and
limited his progress in physical therapy, thus delaying his discharge by several
weeks. His PTSD symptoms and pain management problems ceased following a
modified course of Cognitive Processing Therapy that was administered during
his hospitalization (Table 1).
Table 1










































PTSD has been under-recognized as common element in lung transplantation, but
awareness of PTSD that is exacerbated during the transplant process is increasing
(DiMartini, Dew, Kormos, McCurry, & Fontes, 2007). Risk of developing PTSD
to subsequent trauma increases when there is a history of prior trauma (Breslau,
Peterson, & Schultz, 2008). PTSD in the post-acute period of lung
transplantation may be a cumulative effect of possible prior trauma combined
with medical trauma in the context of medications and anesthesia contributing to
a state of delirium. Consequently, when patients with a history of PTSD
symptoms are exposed to delirium-inducing medications and procedures which
may cue latent memories, even patients that appeared to be stable or coping
adequately with remote traumas may be ill-equipped to psychologically handle
the demands of recovery from lung transplantation. This combination is likely a
contributing factor to the doubled prevalence of PTSD in lung transplant
recipients compared to the general population.
The symptoms of active PTSD include extreme anxiety, hypervigilance,
agitation, social withdrawal, avoidance of trauma reminders, and insomnia,
which have been shown to worsen morbidity and mortality following heart
transplant (Favaro et al., 2011), are yet unstudied in lung transplant. Given that
the course of untreated PTSD is often chronic, exacerbations may continue to
impact the transplant recovery process, manifesting themselves in medical
6 of 11
noncompliance, physical deconditioning, or poor quality of life.
The cases presented illustrate poor disclosure of trauma history and PTSD
symptoms during transplant work-ups. The psychological evaluation for lung
transplantation at this institution includes, at minimum, a 60-min psychological
interview with a PhD level psychologist which explicitly inquires about both
previous exposure to traumatic experience as well as lifetime symptoms of
PTSD. Some patients avoided disclosing trauma exposure and PTSD not only to
the transplant team, but also their family members and caregivers. In instances
were caregivers were aware of previous trauma, they did not disclose it to the
transplant team. Poor disclosure may be due to a constellation of causes
including (1) patient’s lack of awareness/insight, (2) motivation to appear
psychologically stable during evaluation process/obtain transplant, (3)
inadequate inquiry/inappropriate evaluation methods by the transplant team, (4)
greater severity of avoidance symptoms. To address these barriers, transplant
candidates must be provided with specific psychoeducation on both the nature of
PTSD symptomatology and possible ill effects on transplant outcomes.
Subsequently, affected candidates must be offered effective evidence-based
treatments, such as cognitive processing therapy, trauma-focused cognitive
behavioral therapy, narrative exposure therapy, eye movement desensitization
and reprocessing, or prolonged exposure therapy (Morkved et al., 2014; Resick,
Monson, & Chard, 2016; Seidler & Wagner, 2006), to address their PTSD.
Because social desirability is at play in candidate’s disclosure patterns regarding
PTSD, standardized evaluation methods that include validity indices, such as the
Minnesota Multiphasic Personality Inventory-2 Restructured Form (Tellegen et
al., 2003) may need to be employed. Transplant teams must be cognizant of both
the high prevalence of PTSD, its resulting risk factors, and patient’s reluctance to
disclose.
Studies have documented that patients found to be at highest risk for developing
PTSD have a tendency to be younger, without private insurance, diagnosed with
bronchiolitis obliterans syndrome, and more likely to have pulmonary fibrosis
than chronic obstructive pulmonary disease. They were also more likely to report
arousal and re-experiencing symptoms, characteristic of PTSD (Dew et al.,
2012). Moreover, childhood physical or sexual abuse survivorship was common
in 24.2% of lung transplant recipients and associated with decreased survival
(Kennedy et al., 2016). Consequently, remote trauma exposure might affect
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physiological stress reactivity, neuronal changes (Gould & Tanapa, 1999) or
brain development, altogether, if exposure is early enough in life (Perry &
Pollard, 1998), all of which could result in maladaptive coping and place one at
increased risk for psychiatric morbidity. Thus, these known risk factors should
inform the psychological evaluation process to better identify individuals with
PTSD. Psychological intervention and psychiatric consultation should be readily
available in the ICU and inpatient units during the post-acute period to provide
early intervention when PTSD symptoms emerge. Given the high prevalence rate
of PTSD in lung transplant recipients, post-transplant routine screening may be
indicated at 1 week, 1, 3, 6, and 12 months intervals.
AQ3
All presented cases experienced delirium following lung transplantation.
Delirium induced by medical interventions, in the post-acute phase may be a risk
factor for PTSD exacerbation. Risk factors for delirium should, of course, be
minimized when possible by the transplant team. Those experiencing delirium
with known trauma history or PTSD should be closely monitored for PTSD
exacerbation. All patients with delirium but without known trauma or PTSD
history, should still be evaluated for signs of PTSD given a tendency for poor
disclosure. Noncompliance with medical treatment should also be a trigger for
PTSD screening in this population, as it is often a visible indicator of
psychological complications. Further study of lung transplant candidates is
indicated to better understand how pre-existing PTSD symptoms are exacerbated
by delirium and what strategies are most effective at mitigating these risks to
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